# Evaluation of the Long-term Persistence of Hepatitis A Antibodies in Healthy Adults Who Were Vaccinated 21-25 Years Earlier With GlaxoSmithKline (GSK) Biologicals' Hepatitis A Vaccine, Havrix®

> **NCT02124785** · PHASE4 · WITHDRAWN · sponsor: **GlaxoSmithKline**

## Conditions studied

- Hepatitis A

## Interventions

- **PROCEDURE:** Blood sampling

## Key facts

- **NCT ID:** NCT02124785
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-05
- **Primary completion:** 2019-07
- **Final completion:** 2019-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** This study has been cancelled before initiation due to company's prioritisation decisions linked to resources restrictions.
- **Last updated:** 2015-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02124785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02124785, "Evaluation of the Long-term Persistence of Hepatitis A Antibodies in Healthy Adults Who Were Vaccinated 21-25 Years Earlier With GlaxoSmithKline (GSK) Biologicals' Hepatitis A Vaccine, Havrix®". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02124785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*